An observational study in Type 2 Diabetes Mellitus and Vascular Complications, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.
Sponsored by Assiut University · Observational
This cross-sectional study aims to evaluate the association of platelet indices and ABO blood groups with vascular complications in patients with type 2 diabetes mellitus.
Vascular complications are a major cause of morbidity in type 2 diabetes mellitus. Platelet indices and ABO blood groups may be related to these complications.
This observational study will include adult patients with type 2 diabetes mellitus. Patients will be classified into those with and without vascular complications. Platelet indices (MPV, PDW) and ABO blood groups will be assessed.
Adult patients with type 2 diabetes mellitus attending the Internal Medicine Department and Diabetes Center at Assiut University Hospital.
Exclusion Criteria:
Patients with type 2 diabetes mellitus who have microvascular or macrovascular complications.
Patients with type 2 diabetes mellitus who have no microvascular or macrovascular complications.
Mean platelet volume in patients with and without vascular complications
Mean platelet volume (MPV) in femtoliters compared between type 2 diabetes patients with vascular complications and those without vascular complications.
Time frame: Baseline
Mean platelet distribution width
Mean platelet distribution width (PDW) compared between patients with and without vascular complications.
Time frame: Baseline
Distribution of ABO blood groups according to vascular complications
Frequency and percentage of ABO blood groups in patients with and without vascular complications.
Time frame: Baseline
Mean platelet volume according to ABO blood group
Mean platelet volume (MPV) among different ABO blood groups.
Time frame: Baseline
Prevalence of microvascular complications
Proportion of patients with microvascular complications (retinopathy, nephropathy, or neuropathy).
Time frame: Baseline
Prevalence of macrovascular complications
Proportion of patients with macrovascular complications (coronary artery disease, cerebrovascular disease, or peripheral arterial disease).
Time frame: Baseline
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University